Home  |  About  |  PCSK9  |  News  |  Commentary  |  Trials  |  Videos  |  Resources  |  Contact New to PCSK9 Forum Is a 'once-and-done' approach to LDL cholesterol possible? Proof-of-concept for the potential of gene-editing for PCSK9 inhibition Prof. John Chapman, Sorbonne University, Paris, France, discusses this novel proof-of-concept study. Read the report » Question of the month LDL cholesterol lowering and effects on plaque: what can we learn from INTENSITY-HIGH? Prof. John Chapman, Sorbonne University, Paris, France, discusses the rationale for the INTENSITY-HIGH study. Watch the video » News from the 89th European Atherosclerosis Society Congress – Virtual meeting HEYMANS: real-world study in Europe shows that the care of patients with familial hypercholesterolaemia needs to improve Prof. Kausik Ray (Imperial College London, UK) discusses insights from the study. Read the report » Global registry in homozygous familial hypercholesterolaemia highlights the cardiovascular impact of inequity in access to LDL lowering treatments Prof. Derick Raal (University of the Witwatersrand, Johannesburg, South Africa) gives his view. Read the report » More from DA VINCI: Need to improve access to LDL-lowering treatment across Europe Prof. Michal Vrablik (Charles University in Prague, the Czech Republic) discusses new findings from the DA VINCI study. Read the report » Like us For the latest updates, PCSK9 news and analysis. Follow us Hot topics, news and conference reports. YouTube Channel For videos, interviews and webcasts from leading experts. Educational Partners and Supporters Copyright PCSK9 Forum 2021. Please click here to unsubscribe from future mailings. View on the web ​